Shanghai Junshi Biosciences Ltd.
Shanghai Junshi Biosciences, a Shanghai‑based biopharma founded in 2012, develops oncology and autoimmune therapeutics, including its anti‑PD‑1 monoclonal antibody TUOYIR and multiple biosimilars. Strategic partnerships with Eli Lilly, Merck and Coherus amplify its pipeline.
Headquarters: China (CHN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 2,578
- HQ: Shanghai
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.